plat

(redirected from Reteplase)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.
Related to Reteplase: Tenecteplase

plat

A plan or survey map of a parcel of land.Developers file subdivision plats showing block and lot numbers, the dimensions and locations of individual lots, and the dimensions and locations of dedicated streets. Legal descriptions for properties within the subdivision are then made by reference to the recorded plat,such as “Lot 2,Block 3 of Harper Downs II as recorded in Plat Book 213,Page 82, of the Judge of Probate of Jefferson County,Alabama.”

References in periodicals archive ?
Conclusion: The oxidizing cytoplasm of Rosetta-gami and Shuffle T7 in addition to alterations of cultivation parameters could not result in soluble production of reteplase, although the inclusion bodies produced in these two strains might increase the rate of refolding procedure likely due to formation of folding intermediates.
To overcome this problem, reteplase can be targeted to the periplasmic space which has less reducing environment as compared to cytoplasm (6).
Both alteplase and reteplase demonstrate well-defined bell-shaped curves of fibrinolytic activity.
Enzymes that are currently in use for catheter clearance are streptokinase, alteplase, and reteplase (see Table 1).
That proposition is now undergoing definitive testing in the Early Reteplase Thrombolysis in Myocardial Infarction-19 (ER TIMI-19) trial.
Scil Proteins already manufactures Reteplase, a protein for the treatment of myocardial infarction developed by Boehringer Mannheim and Roche, for the commercial market.
Tenders are invited for Reteplase Injection Kit Consisting Of Two Bolusof Reteplase 18 Mg Each Equivalent To 10 Iu
About 60% of patients received streptokinase, 27% received reteplase, and the remaining patients received other agents.
But the value of adding reviparin or a similar agent remains in doubt when patients are treated with the fibrin-specific drugs most often used for thrombolysis in the United States, such as alteplase (tissue plasminogen activator), reteplase, and tenecteplase.
The purpose of this study was to assess the results of the routine use reteplase for prehospital myocardial infarction in a county with a significant rural population.
Both reteplase and alteplase (t-PA) are tissue-plasminogen activators.